View in EDS

Increasing Alcohol Pharmacotherapy Prescribing Rates in Australia: Implementing Evidence‐Based Treatment for Alcohol Use Disorder.

Saved in:
Bibliographic Details
Title: Increasing Alcohol Pharmacotherapy Prescribing Rates in Australia: Implementing Evidence‐Based Treatment for Alcohol Use Disorder.
Authors: Naren, Thileepan (AUTHOR), Membrey, Dean (AUTHOR), MacCartney, Paul (AUTHOR), Kuntsche, Sandra (AUTHOR), Cook, Megan (AUTHOR), Jiang, Heng (AUTHOR), Kuntsche, Emmanuel (AUTHOR)
Source: Drug & Alcohol Review. Nov2025, Vol. 44 Issue 7, p2057-2060. 4p.
Subjects: Alcoholism, Baclofen, Cirrhosis of the liver, Temperance, Drug therapy, Naltrexone, Evidence-based medicine
Geographic Terms: Australia
Abstract: The article focuses on the case of a 32-year-old woman with a history of severe alcohol use disorder (AUD) and Child's Pugh C cirrhosis, highlighting the significant health impacts of alcohol consumption and the potential benefits of alcohol pharmacotherapy. Despite previous treatment attempts, including detoxification and psychosocial support, the patient showed limited improvement until she was prescribed baclofen, which led to a notable reduction in drinking and improved overall health. The commentary emphasizes the underutilization of pharmacotherapy options like naltrexone and acamprosate in Australia, despite their proven effectiveness, and calls for a shift in treatment paradigms to better address the needs of individuals with AUD. The authors advocate for increased access to evidence-based pharmacotherapies to reduce the personal and societal costs associated with alcohol-related harm. [Extracted from the article]
Copyright of Drug & Alcohol Review is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Psychology and Behavioral Sciences Collection
FullText Text:
  Availability: 0
Header DbId: pbh
DbLabel: Psychology and Behavioral Sciences Collection
An: 189063304
AccessLevel: 6
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Increasing Alcohol Pharmacotherapy Prescribing Rates in Australia: Implementing Evidence‐Based Treatment for Alcohol Use Disorder.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Naren%2C+Thileepan%22">Naren, Thileepan</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Membrey%2C+Dean%22">Membrey, Dean</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22MacCartney%2C+Paul%22">MacCartney, Paul</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kuntsche%2C+Sandra%22">Kuntsche, Sandra</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Cook%2C+Megan%22">Cook, Megan</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Jiang%2C+Heng%22">Jiang, Heng</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kuntsche%2C+Emmanuel%22">Kuntsche, Emmanuel</searchLink> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Drug+%26+Alcohol+Review%22">Drug & Alcohol Review</searchLink>. Nov2025, Vol. 44 Issue 7, p2057-2060. 4p.
– Name: Subject
  Label: Subjects
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22Alcoholism%22">Alcoholism</searchLink><br /><searchLink fieldCode="DE" term="%22Baclofen%22">Baclofen</searchLink><br /><searchLink fieldCode="DE" term="%22Cirrhosis+of+the+liver%22">Cirrhosis of the liver</searchLink><br /><searchLink fieldCode="DE" term="%22Temperance%22">Temperance</searchLink><br /><searchLink fieldCode="DE" term="%22Drug+therapy%22">Drug therapy</searchLink><br /><searchLink fieldCode="DE" term="%22Naltrexone%22">Naltrexone</searchLink><br /><searchLink fieldCode="DE" term="%22Evidence-based+medicine%22">Evidence-based medicine</searchLink>
– Name: SubjectGeographic
  Label: Geographic Terms
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22Australia%22">Australia</searchLink>
– Name: Abstract
  Label: Abstract
  Group: Ab
  Data: The article focuses on the case of a 32-year-old woman with a history of severe alcohol use disorder (AUD) and Child's Pugh C cirrhosis, highlighting the significant health impacts of alcohol consumption and the potential benefits of alcohol pharmacotherapy. Despite previous treatment attempts, including detoxification and psychosocial support, the patient showed limited improvement until she was prescribed baclofen, which led to a notable reduction in drinking and improved overall health. The commentary emphasizes the underutilization of pharmacotherapy options like naltrexone and acamprosate in Australia, despite their proven effectiveness, and calls for a shift in treatment paradigms to better address the needs of individuals with AUD. The authors advocate for increased access to evidence-based pharmacotherapies to reduce the personal and societal costs associated with alcohol-related harm. [Extracted from the article]
– Name: AbstractSuppliedCopyright
  Label:
  Group: Ab
  Data: <i>Copyright of Drug & Alcohol Review is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.)
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=pbh&AN=189063304
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1111/dar.70046
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 4
        StartPage: 2057
    Subjects:
      – SubjectFull: Alcoholism
        Type: general
      – SubjectFull: Baclofen
        Type: general
      – SubjectFull: Cirrhosis of the liver
        Type: general
      – SubjectFull: Temperance
        Type: general
      – SubjectFull: Drug therapy
        Type: general
      – SubjectFull: Naltrexone
        Type: general
      – SubjectFull: Evidence-based medicine
        Type: general
      – SubjectFull: Australia
        Type: general
    Titles:
      – TitleFull: Increasing Alcohol Pharmacotherapy Prescribing Rates in Australia: Implementing Evidence‐Based Treatment for Alcohol Use Disorder.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Naren, Thileepan
      – PersonEntity:
          Name:
            NameFull: Membrey, Dean
      – PersonEntity:
          Name:
            NameFull: MacCartney, Paul
      – PersonEntity:
          Name:
            NameFull: Kuntsche, Sandra
      – PersonEntity:
          Name:
            NameFull: Cook, Megan
      – PersonEntity:
          Name:
            NameFull: Jiang, Heng
      – PersonEntity:
          Name:
            NameFull: Kuntsche, Emmanuel
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 11
              Text: Nov2025
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 09595236
          Numbering:
            – Type: volume
              Value: 44
            – Type: issue
              Value: 7
          Titles:
            – TitleFull: Drug & Alcohol Review
              Type: main
ResultId 1